SCHEMBL7917545

SCHEMBL7917545

O=CC(c1cccc(F)c1)c1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
IDO1 P14902 1/20 0.43
TDO2 P48775 1/20 0.43
NFE2L2 Q16236 2/20 0.41
CNR2 P34972 1/20 0.39
ACHE P22303 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
THPO P40225 1/20 0.38
NPC1 O15118 1/20 0.38
CHRM5 P08912 1/20 0.38
GRM5 P41594 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515851 0.94 IDO1 (0.47) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL3403146 0.88 CYP11B1 (0.41) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL7861158 0.88 HDAC4 (0.42) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL3905843 0.86 CES2 (0.44) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL2562362 0.83 HDAC4 (0.47) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL7818627 0.82 AKR1C3 (0.44) CES2CES1
SCHEMBL7862422 0.82 HDAC4 (0.39) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL15545304 0.81 HDAC4 (0.41) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL15528140 0.81 HDAC4 (0.41) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL7828556 0.80 MEN1 (0.34) HDAC4HDAC7HDAC5CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174898-B1 TREATING FILARIAE IN LYMPHATIC SYSTEM BY ADMINISTERING N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS IN WHICH A SUBSTITUTED ALKYL CHAIN FORMS PART OF N-SUBSTITUENT AND SALTS NOVO NORDISK A/S (DK) 2001-01-16 US disclosed
EP-0374801-B1 Novel N-sustituted azaheterocyclic carboxylic acids NOVO NORDISK AS (DK) 1997-03-19 EP disclosed
EP-0430771-B1 Isoindolone derivatives, their preparation and their use as intermediates for the preparation of substance P antagonists RHONE POULENC SANTE (FR) 1994-07-20 EP disclosed
EP-0429366-B1 Isoindolone derivatives, their preparation and pharmaceutical compositions containing them RHONE POULENC SANTE (FR) 1994-03-16 EP disclosed
US-5214057-A Used as analgesic, anxiolytic, antidepressant, hypnotic and for treating epilepsy and muscular disorder NOVO NORDISK A/S (DK) 1993-05-25 US disclosed
US-5112988-A ISOINDOLONE DERIVATIVES RHONE-POULENC SANTE (FR) 1992-05-12 US disclosed
US-5102667-A Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders RHONE-POULENC SANTE (FR) 1992-04-07 US disclosed
US-5071859-A Analgesic, antianxiolytic, antiepileptic, antidepressant; gammaa-aminobutyric acid inhibitor NOVO NORDISK A/S, A CORP. OF DENMARK (DK) 1991-12-10 US disclosed
EP-0430771-A1 Isoindolone derivatives, their preparation and their use as intermediates for the preparation of substance P antagonists RHONE-POULENC SANTE (FR) 1991-06-05 EP disclosed
EP-0429366-A1 Isoindolone derivatives, their preparation and pharmaceutical compositions containing them RHONE-POULENC SANTE (FR) 1991-05-29 EP disclosed
EP-0374801-A2 Novel N-sustituted azaheterocyclic carboxylic acids NOVO NORDISK A/S (DK) 1990-06-27 EP disclosed